D-0631-2021 Class III Terminated
FDA drug recall D-0631-2021 was initiated by AVKARE Inc. on Jun 9, 2021 and is designated Class III. Reason for recall: Failed Impurities Specification: Out of specification when measuring the impurity degradant D level. The recall status is terminated (terminated Jun 2, 2023). Affected quantity: 10 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 23, 2021
- Initiation Date
- Jun 9, 2021
- Termination Date
- Jun 2, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10 cartons
Product description
Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478. NDC 50268-661-13
Reason for recall
Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.
Distribution pattern
Distributed in Los Angeles California
Code information
Lot: 38617 Exp. 10/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0631-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026